AZD8205 is a drug-linker conjugate featuring a cleavable linker and the exatecan payload, designed for use in antibody-drug conjugates (ADCs) targeting B7-H4. This research tool enables the study of targeted chemotherapy in oncology, with applications in both in vitro and in vivo models for evaluating ADC efficacy and mechanism.